Merck & Company, Inc. Revenue 2007–2025
Merck & Company, Inc. reported $65.01B of revenue for fiscal 2025. That was 1.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +56.6%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $65.01B | +1.3% |
| FY 2024 | $64.17B | +6.7% |
| FY 2023 | $60.12B | +1.4% |
| FY 2022 | $59.28B | +21.7% |
| FY 2021 | $48.70B | +17.3% |
| FY 2020 | $41.52B | +6.1% |
| FY 2019 | $39.12B | -7.5% |
| FY 2018 | $42.29B | +5.4% |
| FY 2017 | $40.12B | +0.8% |
| FY 2016 | $39.81B | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | -100.0% |
| FY 2010 | $45.99B | +67.7% |
| FY 2009 | $27.43B | +15.0% |
| FY 2008 | $23.85B | -1.4% |
| FY 2007 | $24.20B | — |
Source: Merck & Company, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MRK 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Merck & Company, Inc. reported $65.01B of revenue for fiscal 2025. That was 1.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +56.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Merck & Company, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMerck & Company, Inc. — frequently asked questions
What is Merck & Company, Inc.'s revenue?
Merck & Company, Inc. (MRK) reported revenue of $65.01B for fiscal year 2025, per its SEC filings.
How has Merck & Company, Inc.'s revenue changed over time?
Between fiscal 2007 and 2025, MRK's revenue grew at roughly 5.6% per year (compound annual rate), from $24.20B to $65.01B.
Where does this data come from?
Figures are computed from Merck & Company, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.